Heart Failure Pharmacology
Sort by:
ACC 2022 Conference Coverage
ACC 2022: Mavacamten Treatment for Patients With Obstructive Hypertrophic Cardiomyopathy
FEATURING
Florian Rader
- 1,480 views
- April 7, 2022
- 4
Marc Bonaca
VOYAGER PAD Trial: Protecting the Patient Undergoing Lower Extremity Revascularization for Symptomatic PAD
- 1,480 views
- November 11, 2020
- 9
Houston Methodist DeBakey Heart and Vascular Center
Evaluation of New-Onset Heart Failure
FEATURING
Mark Drazner
- 1,474 views
- February 10, 2023
- 10
ACC 2022 Conference Coverage
ACC 2022: SGLT2i in Heart Failure - HFrEF, HFpEF, Class Effect?
FEATURING
Stephen Greene
- 1,447 views
- April 12, 2022
- 10
Scripps Health
Reading Between the Guidelines for Management of Heart Failure
FEATURING
Lynne Warner Stevenson
- 1,425 views
- June 13, 2023
- 9
AHA 2022 Conference Coverage
AHA 2022: GDMT for HFpEF - What Do We and Don't We Know?
FEATURING
Marat Fudim
- 1,412 views
- November 30, 2022
- 11
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With or Without Chronic Kidney Disease and/or Diabetes
FEATURING
Maria Costanzo
- 1,385 views
- April 16, 2024
- 18
American Heart & Vascular Institute
Sex Differences in Heart Failure: Looking Beyond the Surface. How Can We Avoid Biases in Treatment of Heart Failure in Women?
FEATURING
Martha Gulati
- 1,357 views
- September 9, 2020
- 5
UCLA Health
2023 State of the Art Medication Therapies for Heart Failure
FEATURING
Gregg Fonarow
- 1,356 views
- October 12, 2023
- 14
Houston Methodist DeBakey Heart and Vascular Center
Group 2 Pulmonary Hypertension: Isn't it Just Heart Failure?
FEATURING
Hyeon-Ju Ali
- 1,333 views
- June 14, 2023
- 14
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation
FEATURING
Michelle Kittleson
- 1,319 views
- February 8, 2022
- 11
ACC 2023 Conference Coverage
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
FEATURING
Barry Borlaug
- 1,317 views
- March 15, 2023
- 9
Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension
Diagnosis and Management of Pulmonary Hypertension with HFpEF
FEATURING
Sanjiv J. Shah
- 1,316 views
- October 15, 2018
- 9
Mount Sinai Advanced Heart Disease Symposium 2017
What’s in Store for the Future of Heart Failure Therapy
- 1,299 views
- January 23, 2018
- 6
CCM® Therapy
AHA 2020 - Classifying Heart Failure Using NYHA Functional Class Assessment
FEATURING
William Abraham
- 1,283 views
- November 20, 2020
- 10
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Management of Sleep Disordered Breathing in Heart Failure: What Are the Benefits of Treating Obstructive Sleep Apnea with Positive Airway Pressure? How to Treat Central Sleep Apnea?
FEATURING
Robert Owens
- 1,280 views
- February 8, 2021
- 15
Top Ten Topics in Clinical Cardiology 2021
Optimizing Heart Failure Therapy: Selection, Sequence, Substitution?
FEATURING
Javed Butler
- 1,278 views
- November 2, 2021
- 16
Courage and Innovation Symposium: Heart Failure & Heart Transplantation
Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sight
FEATURING
Nitasha Sarswat
- 1,261 views
- April 27, 2022
- 13
Scripps Health
2021 Primary Care Clinical Trial Highlights: OSA Evals, Breast Cancer Prevention, Hep C Screening, AF and HFrEF
FEATURING
Joel C. Diamant
- 1,248 views
- August 26, 2021
- 5
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
FEATURING
Anuradha Lala-Trindade
- 1,243 views
- December 15, 2021
- 17
The Texas Heart Institute
Antihyperglycemic Medications for CV Risk Reduction: a Cardiologist's Perspective
FEATURING
Darren K. Mcguire
- 1,230 views
- January 18, 2024
- 10